Share on StockTwits

Monsanto Company (NYSE: MON) was the recipient of a ratings changes during the seven days:

  • Monsanto Company had its price target raised by analysts at Canaccord Genuity from $135.00 to $155.00. They now have a “buy” rating on the stock.
  • Monsanto Company had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a $135.00 price target on the stock, up previously from $128.00.
  • Monsanto Company had its “outperform” rating reaffirmed by analysts at Credit Suisse. They now have a $148.00 price target on the stock, up previously from $134.00.
  • Monsanto Company had its “buy” rating reaffirmed by analysts at Deutsche Bank. They now have a $145.00 price target on the stock, up previously from $130.00.
  • Monsanto Company had its price target raised by analysts at Monness Crespi & Hardt from $131.00 to $140.00. They now have a “buy” rating on the stock.
  • Monsanto Company had its “buy” rating reaffirmed by analysts at Citigroup Inc.. They now have a $146.00 price target on the stock, up previously from $130.00.

Shares of Monsanto Company (NYSE:MON) traded up 0.31% on Tuesday, hitting $124.70. The stock had a trading volume of 1,204,151 shares. Monsanto Company has a 52 week low of $94.00 and a 52 week high of $128.79. The stock’s 50-day moving average is $120.4 and its 200-day moving average is $114.. The company has a market cap of $65.417 billion and a price-to-earnings ratio of 24.99. Monsanto Company also saw some unusual options trading activity on Monday. Traders bought 4,856 put options on the company. This represents an increase of 113% compared to the typical volume of 2,277 put options.

Monsanto Company (NYSE:MON) along with its subsidiaries, is a provider of agricultural products for farmers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.